![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Patient’s own immune cells may blunt viral therapy for brain cancer
Doctors now use cancer-killing viruses to treat some patients with lethal, fast-growing brain tumors....
Discovery offers new treatment for epilepsy
New drugs derived from components of a specific diet used by children with severe,...
Drug resistance biomarker could improve cancer treatmentDrug resistance biomarker could improve cancer treatment
Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that...
Discovery of molecular pathway of Alzheimer’s disease reveals new drug targets
The discovery of the molecular pathway that drives the changes seen in the brains...
TGen, Scottsdale Healthcare lead worldwide study of new drug for patients with pancreatic cancer
A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic...
Study shows large-scale genomic testing feasible, impacts therapy
Targeted cancer therapy has been transforming the care of patients with non-small-cell lung cancer...
Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to...
Cook Medical has received U.S. Food and Drug Administration (FDA) marketing approval for the...
Bristol-Myers Squibb Foundation’s Together on Diabetes™ marks World Diabetes Day
The Bristol-Myers Squibb Foundation has marked World Diabetes Day and the second anniversary of...
The largest clinical study of Bayer’s Xarelto® (rivaroxaban)
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study...
A completely new way of delivering anti-cancer drugs
A completely new way of delivering anti-cancer drugs to tumours, using 'minicells' derived from...